Fragment-based lead discovery: leads by design
Robin A. E. Carr, Miles Congreve, Christopher W. Murray et al. · Drug Discovery Today · 2005
Cited by 343 works. doi:10.1016/s1359-6446(05)03511-7
Authors
References
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
- Discovering High-Affinity Ligands for Proteins: SAR by NMR
- Ligand efficiency: a useful metric for lead selection
- The Design of Leadlike Combinatorial Libraries
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
- Is There a Difference between Leads and Drugs? A Historical Perspective
- A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
- A ‘Rule of Three’ for fragment-based lead discovery?
- The maximal affinity of ligands
- Navigating chemical space for biology and medicine